Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2022 Mar 19;158:107025. doi: 10.1016/j.ypmed.2022.107025

Missed routine pediatric care and vaccinations in US children during the first year of the COVID-19 pandemic

Chloe A Teasdale a,b,c,, Luisa N Borrell a, Yanhan Shen a, Spencer Kimball d, Rebecca Zimba a,b, Sarah Kulkarni b, Madhura Rane b, Michael L Rinke e, Sasha A Fleary b,f, Denis Nash a,b
PMCID: PMC8933962  PMID: 35318030

Abstract

The COVID-19 pandemic has decreased uptake of pediatric preventive care, including immunizations. We estimate the prevalence of missed pediatric routine medical visits and vaccinations over the first year of the COVID-19 pandemic. We conducted a cross-sectional online survey of 2074 US parents of children ≤12 years in March 2021 to measure the proportion of children who missed pediatric care and vaccinations over the first 12 months of the COVID-19 pandemic. Poisson regression models were fitted to estimate adjusted prevalence ratios (aPR). All analyses were weighted to represent the target population. Overall, 41.3% (95%CI 38.3–43.8) of parents reported their youngest child missed a routine medical visit due to the COVID-19 pandemic. Missed care was more common among children ≥2 years compared to <2 years (aPR 1.82; 95%CI 1.47–2.26) and Hispanics compared to non-Hispanic Whites (aPR 1.31; 95%CI 1.14–1.51). A third of parents (33.1%; 95%CI 30.7–35.5) reported their child had missed a vaccination. Compared to the 2019-20 flu season, pediatric influenza vaccination decreased in 2020–21 (51.3% vs. 62.2%; p < 0.0001). A high proportion of US children ≤12 years missed routine pediatric care during the COVID-19 pandemic. Catch-up efforts are needed to ensure continuity of preventive care for all children.

Abbreviations: AAPOR, American Association for Public Opinion Research; CI, Confidence interval; CUNY, City University of New York; IQR, Interquartile range; MMR, Measles-mumps-rubella; NH, Non-Hispanic; PR, Prevalence ratio; STROBE, Strengthening the Reporting of Observational Studies in Epidemiology; US, United States; USD, US dollars

1. Introduction

The SARS-CoV-2 (COVID-19) pandemic has significantly disrupted the lives of adults and children in the United States (US). In March 2020, the US Centers for Disease Control and Prevention (CDC) called for social distancing and, during the first months of the pandemic, some states enacted stay at home orders (Schuchat and Team, 2020). Early in the pandemic, the CDC also recommended medical providers delay non-emergency and elective care to preserve the capacity of the healthcare system and to minimize transmission risk (US Centers for Disease Control and Prevention (CDC), 2020). These policies, as well as personal concerns about exposure, may have resulted in lower uptake of routine pediatric medical care which could have significant long-term impact on the health of children, their families and communities.

Several studies have shown declines in vaccination uptake among children during the COVID-19 pandemic. In May 2020, the CDC reported a drop in orders from the Vaccines for Children Program (VFC) (Santoli et al., 2020) which provides free immunizations to half of US children (Walsh et al., 2016), and data from immunization registries confirmed decreased vaccination uptake early in the COVID-19 pandemic (Bramer et al., 2020; Langdon-Embry et al., 2020; Ackerson et al., 2021). In New York City, vaccinations for children <24 months returned to pre-COVID levels by June 2020, however uptake remained 35% lower among older children (Langdon-Embry et al., 2020). In Ohio, a decline in medical care visits attended by infants and young children during the first six months of the COVID-19 pandemic led to lower measles-mumps-rubella (MMR) vaccination rates (Bode et al., 2021).

There is less information about the extent of missed routine pediatric care however an analysis by the Commonwealth Fund of data from 50,000 health care providers across the US found that in March 2020, pediatric outpatient care visits declined by 70% for children <18 years and that pediatric visits remained below pre-pandemic levels by October 2020 (Mehrotra et al., 2020). In addition, from March to May of 2020, half a million fewer US children received blood lead level screening, 10,000 of whom may have had elevated levels requiring interventions (Courtney et al., 2021). As well as highlighting concerning gaps in vaccination coverage, these data are suggestive of significant and potentially harmful disruptions to routine pediatric preventive care as a result of the COVID-19 pandemic.

Evidence in adults suggests that missed care during the COVID-19 pandemic may have contributed to increased mortality from causes other than SARS-CoV-2 (Woolf et al., 2020; Weinberger et al., 2020). While the consequences of missed care for children may be less severe, they remain significant. The American Academy of Pediatrics (AAP) guidelines call for monthly visits for infants up to six months and annual wellness visits for children >2 years (Hagan et al., 2017). CDC's pediatric immunization schedule includes 15 vaccinations (plus boosters) and immunization for seasonal influenza (CDC, 2020). Avoidance of pediatric care could lead to missed diagnoses of developmental delays, emotional problems, physical disabilities and other conditions identified through routine screening. Missed vaccinations could have serious consequences for the health of children and communities and contribute to outbreaks of vaccine-preventable illnesses (Sull et al., 2014; Zucker et al., 2020; Bleser et al., 2019).

There are few data on the prevalence of missed care visits among US children and little information about which children are at highest risk. In order to quantify the prevalence of missed routine pediatric preventive care as a result of the COVID-19 pandemic, including receipt of vaccinations, and to identify the characteristics of children at risk for missed care, we conducted an online survey of US parents of children ≤12 years.

2. Methods

2.1. Sampling methodology

The cross-sectional survey of parents and caregivers (‘parents’) of children ≤12 years from across the US was conducted from March 9 through April 2, 2021. Participants were English and Spanish speaking adults ≥18 years who identified as a primary caregiver of a child ≤12 years who had taken the child to a medical visit in the past two years. The sample was recruited via Qualtrics, an online survey administration service maintaining a database of millions of US participants across multiple non-probability survey panels identified through social media platforms and parent networks (ie, business-to-business partners used by Qualtrics) (Miller et al., 2020).We followed guidelines from the American Association for Public Opinion Research (AAPOR) (American Association for Public Opinion Research (AAPOR), 2022) and Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) for cross-sectional studies (Strengthening the reporting of observational studies in epidemiology (STROBE), 2007). The survey instrument was developed for this study with questions modeled on the 2020 National Survey of Children's Health (US Census Bureau (USC), 2020). The study was approved by the City University of New York (CUNY) Graduate School of Public Health institutional review board.

Proportionate sampling based on sex, race, ethnicity, education and US region was utilized to weight the sample to the target population of US parents of children ≤12 years according to 2019 US Census data (USC, 2019). The target sample size was 2000 to obtain precise estimates for race/ethnicity groups; the final sample included 2074 participants. Respondents were recruited online through social media platforms and partner networks using standard procedures (Miller et al., 2020); individuals opting in were linked to the anonymous online survey. After completing screening questions, eligible participants provided medical care and vaccination information about the youngest child in the household (in order to achieve an adequate sample of younger children), as well as socio-demographic questions about the parent and household. (eAppendix) All data were de-identified. In accordance with the AAPOR guidelines for reporting opt-in non-probability panel data, participation rates cannot be estimated as the sampling frame is unknown (American Association for Public Opinion Research (AAPOR), 2022).

2.2. Study data and outcomes

The primary outcomes were prevalence of missed routine care visits and missed routine vaccinations (not including influenza) in children since the start of the COVID-19 pandemic as reported by parents. The survey asked, “Have you avoided scheduling or cancelled a scheduled routine well visit (check-up) for the child because of the COVID-19 epidemic?” and “Has your child's pediatrician or medical care provider contacted you to tell you or are you aware that your child is due for a vaccine, missed a vaccination or needs to catch up on vaccines? This does not include flu vaccine”. The wording of this question differed from missed visits as most parents may be unaware of when their child is due for a vaccination until it has been missed and they are notified by a care provider. Response options for both questions were yes, no, don't know and prefer not to answer. (eAppendix).

Secondary outcomes included whether the child attended a medical visit following missed care (i.e. make-up visit) and whether the parent planned to take the child to get a missed vaccination. Parents reporting missed visits and vaccinations were asked to select the primary reason for missed care from a list of options. Secondary outcomes also included where the child had attended medical care since the start of the COVID-19 pandemic (with multiple response options) and whether the child had received influenza vaccinations in the 2019–20 and 2020–21 flu seasons (measured as an additional indicator of missed care).

Parents reported demographic information for the child and themselves, including age and race/ethnicity, as well as information about whether the child had health insurance covering some or all doctor visit costs, and whether the child was attending in-person school or daycare ≥1 day per week. Race and ethnicity were asked as separate questions. We report outcomes for the largest race/ethnicity groups and include a ‘non-Hispanic other’ category which includes anyone not identified as Hispanic, Latino/a or Spanish origin, and reporting race as American Indian, Alaska Native, Pacific Islander or ‘other’. Child's age was calculated based on reported month and year of birth (using the first of the month for all birthdates) and age groups were based on the CDC's immunization schedule which includes more vaccinations for children <7 years compared to those ≥7 years (CDC, 2020) (we further divided the younger group to examine children <2 years). Information on the household included the number of children 0–12 years of age, household income and region of the US (based on reported zip code).

2.3. Statistical analyses

Descriptive statistics on the sample population are presented as raw frequencies and weighted percentages. Prevalence estimates for study outcomes are shown as proportions with 95% confidence intervals (CI) and were examined overall, and by the child's race/ethnicity (non-Hispanic (NH) Black, Asian, NH White, Hispanic and NH Other) and age group (<2 years, 2–6 years and 7–12 years). Rao-Scott adjusted Pearson chi-square tests were used to compare prevalence of outcomes across race/ethnicity and age groups.

Poisson regression models with robust standard errors were fitted to estimate adjusted prevalence ratios for each outcome and included demographic characteristics of the child, parent and household (parent race/ethnicity was excluded from adjusted models due to collinearity with child's race/ethnicity). Parents reporting “don't know” or “prefer not to answer” for missed care (N = 43) or missed vaccinations (N = 95) were excluded from regression models. To examine potential bias from these exclusions, we ran models including parents reporting “don't know” or “prefer not to answer” with the “yes” and “no” groups for each outcome (estimates did not change). All levels of demographic characteristics in the models were included but some were not reported due to small sample size, and thus, unreliable estimates.

For the examination of prevalence of seasonal influenza vaccination in 2019–20 compared to 2020–21, only children estimated to be >6 months (i.e. eligible to be vaccinated) by the end of each flu season were included. Rao-Scott adjusted chi-square tests were used to examine differences in influenza vaccination by year. Sample weights were used in all analyses to estimate prevalence of outcomes for the youngest child of parents of US children ≤12 years. Analyses were conducted in SAS 9.4 (SAS Institute Inc., Cary, NC, USA).

3. Results

Table 1 shows the sample characteristics. The median age of children was 4.8 years (interquartile range [IQR] 1.7–8.3), most (92.0%) had health insurance and half (49.7%) were reported to be attending in-person school or daycare in March 2021. Overall, 41.3% (95%CI 38.8–43.8) of parents reported a missed routine medical visit for their child due to the COVID-19 pandemic (Table 2 ). Prevalence of missed visits differed by race/ethnicity and age. Roughly half of Hispanic children (48.5%; 95%CI 43.1–53.9) missed a visit whereas prevalence was lowest among NH Black (34.9%; 95%CI 27.6–42.2) and NH Other children (30.6%; 95%CI 23.0–38.3) missed visits (p < 0.001). While a quarter of children <2 years (24.6%; 95%CI 19.9–29.3) missed a visit, almost half of 2–6-year-olds (44.9%, 95%CI 40.8–49.1%) and 7–12-year-olds (45.2%, 95%CI 41.4–49.1) missed visits (p < 0.001). Among parents reporting missed visits, 65.7% (95%CI 61.9–69.5) cited fear of COVID-19 exposure as the primary reason and 78.7% (95%CI 75.7–81.8%) reported their child subsequently attended a make-up visit.

Table 1.

Characteristics of US children ≤12 years and parents: March 9–April 2, 2021.

Characteristics N Weighted %
Total sample 2074 100.0
Child
Age, median (IQR) 4.8 (1.7–8.3)
 <2 years 371 18.6
 2–6 years 831 40.3
 7–12 years 872 41.1
Sex
 Female 1046 49.5
 Male 1022 50.3
 Missing 6 0.2
Race/ethnicity
 Non-Hispanic black 200 10.6
 Asian 99 3.7
 Non-Hispanic white 1099 50.5
 Hispanic 488 25.9
 Non-Hispanic other a 188 9.3
Has health insurance
 Yes 1914 92.0
 No 149 7.4
 Don't know 11 0.6
Attending in person school/daycare ≥ 1 day per week
 Yes 1098 49.8
 No 969 50.0
 Don't know 7 0.2
Parent
Age
 18–29 years 366 20.3
 30–44 years 1387 65.1
 45+ years 321 14.6
Sex
 Female 1270 60.1
 Male 794 39.3
 Transgender/other 10 0.6
Race/ethnicity
 Non-Hispanic black 219 11.3
 Asian 129 4.6
 Non-Hispanic white 1159 53.3
 Hispanic 467 25.4
 Non-Hispanic other a 100 5.4
Education (highest completed)
 High school or less 482 30.7
 Some college or tech school 546 31.4
 Completed college or more 1015 36.5
 Prefer not to say 31 1.4
Household
Number children ≤ 12 years
 1 1059 50.8
 2 751 34.8
 3 or more 264 14.4
Income USD
 <$25,000 331 20.3
 $25,000–$49,999 472 24.6
 $50,000–$99,999 587 27.4
 ≥$100,000 617 23.9
 Prefer not to say/Don't know 67 3.8
Region (US)
 Northeast 550 15.7
 South 684 39.0
 Midwest 442 21.0
 West 398 24.3

Abbreviations: IQR, interquartile range; US, United States; USD, US dollars.

a

Non-Hispanic other race/ethnicities included participants who identified as American Indian, Alaska native, Pacific islander or ‘other’.

Table 2.

Prevalence of missed routine care visits and vaccinations among US children ≤12 years as reported by parents as of March 2021.



Child race/ethnicity
Child age

All US
Non-Hispanic black
Asian
Non-Hispanic white
Hispanic
Non-Hispanic other
<2 years
2–6 years
7–12 years
%a (95%CI) % (95%CI) % (95%CI) % (95%CI) % (95%CI) % (95%CI) % (95%CI) % (95%CI) % (95%CI)
Missed routine visit 41.3 (38.8–43.8) 34.9 (27.6–42.2) 38.6 (27.4–49.7) 41.1 (37.6–44.5) 48.5 (43.1–53.9) 30.6 (23.0–38.2) 24.6 (19.9–29.3) 44.9 (40.8–49.1) 45.2 (41.4–49.1)
p-valueb <0.001 <0.001
Reason for missed visit
Doctor's office closed 17.1 (13.9–20.2) 19.6 (8.3–31.0) 11.6 (0.1–23.0) 16.6 (12.2–21.1) 19.3 (13.1–25.5) 10.0 (2.3–17.1) 12.6 (5.3–20.0) 17.3 (11.8–22.8) 17.9 (13.7–22.2)
COVID-19 exposure concern 65.7 (61.9–69.5) 67.5 (54.6–80.3) 81.0 (67.4–94.7) 67.0 (61.8–72.1) 61.6 (53.9–69.2) 64.3 (50.7–78.0) 61.2 (50.8–71.6) 67.3 (61.2–73.5) 65.2 (59.8–70.6)
Too busy to attend 3.8 (2.2–5.5) 2.0 (0–6.0) 1.7 (0–5.2) 2.0 (0.7–3.3) 7.4 (2.7–12.0) 5.2 (0–11.2) 4.0 (0–8.1) 4.1 (1.3–6.8) 3.6 (1.2–6.0)
Appointments inconvenient 10.7 (8.5–13.0) 9.2 (1.4–16.9) 5.7 (0–13.1) 11.7 (8.6–14.8) 8.8 (4.8–12.7) 17.2 (6.3–28.1) 15.3 (7.4–23.1) 8.7 (5.8–11.7) 11.6 (8.0–15.1)
Otherc 2.7 (1.5-3.8)
p-value 0.08 0.24
Child subsequently attended visit 78.7 (75.7–81.8) 69.7 (58.1–81.3) 83.6 (68.1–99.1) 81.4 (77.4–85.4) 78.9 (73.0–84.8) 67.5 (54.4–80.6) 84.4 (77.0–91.9) 80.5 (75.9–85.1) 75.6 (70.8–80.4)
p-value 0.11 0.12
Missed vaccination 33.1 (30.7–35.5) 32.1 (24.5–39.8) 48.0 (36.6–59.4) 34.6 (31.2–37.9) 32.7 (27.8–37.6) 21.2 (14.3–28.1) 34.0 (28.3–39.7) 31.8 (27.9–35.6) 34.0 (59.3–66.7)
p-value 0.11 0.12
Plans to take child to get needed vaccination 65.1 (62.7–67.6) 52.5 (44.8–60.2) 69.4 (59.5–79.3) 68.7 (65.4–72.1) 62.4 (57.2–67.6) 65.7 (58.2–73.2) 72.4 (67.0–77.7) 63.9 (59.9–68.0) 63.0 (59.3–66.7)
p-value 0.01 0.02
Reason for not taking child to get vaccination (among no/Don't know)
Doctor's office closed 16.2 (12.8–19.6) 15.6 (7.3–23.8) 15.4 (1.1–29.6) 12.5 (8.4–16.6) 24.3 (16.1–32.6) 10.7 (2.8–18.6) 13.0 (5.5–20.5) 17.5 (11.5–23.5) 16.0 (11.4–20.5)
COVID-19 exposure concern 39.2 (34.8–43.6) 30.8 (20.6–41.0) 54.8 (34.8–74.9) 39.6 (32.6–46.6) 41.6 (33.0–50.1) 38.4 (25.8–50.9) 37.6 (25.9–49.2) 38.5 (31.6–45.5) 40.4 (33.8–47.0)
Too busy to attend 8.9 (6.7–11.2) 7.0 (1.5–12.5) 3.6 (0–9.1) 10.7 (7.0–14.3) 5.5 (2.0–9.0) 15.7 (5.8–25.6) 10.2 (3.9–16.5) 6.7 (3.6–9.8) 10.6 (6.9–14.3)
Do not want child to receive vaccination 19.9 (16.1–23.6) 29.2 (18.1–40.3) 11.1 (0–22.9) 20.1 (14.0–26.1) 16.7 (10.6–22.8) 16.7 (7.2–26.2) 26.8 (16.5–37.2) 20.4 (14.1–26.8) 17.1 (12.1–22.2)
Other 15.8 (12.7–18.8) 17.4 (9.1–25.7) 15.1 (0.8–29.4) 17.2 (12.3–22.0) 11.9 (6.8–17.0) 18.6 (8.2–28.9) 12.4 (5.5–19.4) 16.8 (11.8–21.9) 15.9 (11.4–20.4)
p-value 0.02 0.61
Child has not received all medical care needed 28.9 (26.6–31.3) 22.8 (16.2–29.3) 38.6 (27.5–49.7) 29.9 (26.6–33.1) 31.2 (26.0–36.3) 21.0 (13.3–28.7) 21.4 (15.7–27.2) 27.1 (23.3–30.9) 34.1 (30.5–37.7)
p-value 0.03 0.001
Influenza vaccination
2019–2020 62.2 (59.6–64.8) 54.7 (46.3–63.1) 78.0 (68.0–88.1) 63.8 (60.3–67.3) 60.6 (55.0–66.2) 59.2 (50.9–67.5) 54.3 (44.1–64.6) 63.7 (59.7–67.6) 61.6 (57.9–65.3)
2020–2021 51.3 (48.7–53.9) 44.8 (36.9–52.6) 73.0 (62.5–83.5) 53.8 (50.2–57.3) 48.0 (42.5–53.5) 45.3 (36.8–53.7) 50.2 (43.4–57.0) 51.6 (47.5–55.8) 51.3 (47.4–55.1)
p-value 2019–20 vs. 2020–21 <0.001

Abbreviations: CI = confidence interval; IQR = interquartile range; US = United States; USD = US dollars.

a

Survey weights applied to sample to represent US population of parents by race, ethnicity, sex, education and region.

b

p-values from Rao adjusted Pearson chi-squared tests to compare expected to observed frequencies among groups by characteristic for parent's willingness to vaccinate their youngest child (i.e. whether willing to vaccinate youngest child differed by sex of the child, etc.);

c

Categories are not presented in the table as they yielded unreliable standard error estimates.

One third (33.1%; 95%CI 30.7–35.5) of parents reported their child had missed a vaccination since the start of the COVID-19 pandemic and 65.1% (95% 62.7–67.6) of these parents reported planning to take their child to receive the missed vaccination (Table 2). Plans to take a child for a missed vaccination were highest among parents of Asian children (69.4%; 95%CI 59.5–79.3) and lowest among non-Hispanic Blacks (52.5%; 95%CI 44.8–60.2; p = 0.01). Parents of children <2 years were also more likely to report plans to take the child for a missed vaccination compared to parents of children 7–12 years (72.4%, 95%CI 67.0–77.7 vs. 63.0%. 95%CI 59.3–66.7; p = 0.02). The most commonly reported reasons for not wanting to a take a child for a vaccination were fear of exposure to COVID-19 (39.2%; 95%CI 34.8–43.6) and not wanting the child to receive the vaccination (19.9%; 95%CI 16.1–23.6).

Overall, 28.9% (95%CI 26.6–31.3) of parents felt their child had not received all of the medical care she or he needed as a result of the COVID-19 pandemic (Table 2). While 38.6% (95%CI 27.5–49.7) of Asian parents reported this, only 22.8% (95%CI 16.2–29.3) of NH Blacks felt this way (p = 0.03). Parents of children 7–12 years were also more likely to say their child had not received needed care compared to parents of children <2 years (34.1%; 95%CI 30.5–37.7 vs. 21.4%; 95%CI 15.7–27.2; p = 0.001). Receipt of influenza vaccination was lower in 2020–21 compared to 2019–20 (Table 2). In the pre-COVID flu season of 2019–20, 62.2% (95%CI 59.6–64.8) of parents reported their child received influenza vaccination compared to 51.3% (95%CI 48.7–53.9) in 2020–21 (p < 0.001) (Fig. 1 ).

Fig. 1.

Fig. 2

Receipt of influenza vaccination among US children ≤12 years of age in 2019–20 vs. 2020–21 – parental report (survey conducted March 2021).

In adjusted models, compared to children <2 years, those 2–6 years (aPR 1.82; 95%CI 1.47–2.26) and 7–12 years (aPR 1.86; 95%CI 1.48–2.33) were more likely to have a missed visit due to the COVID-19 pandemic (Table 3 ). Hispanic children were also more likely to have missed visits compared to NH White children (aPR 1.31; 95%CI 1.14–1.51). Parents with three or more children were more likely to report missed visits compared to those with one child (aPR 1.24; 95%CI 1.03–1.49) while parents with income $25,000–$49,000 were less likely to report missed care compared to those with income ≥$100,000 (aPR 0.76; 95%CI 0.63–0.91) (Table 3). In separate adjusted models, female parents were less likely to report missed vaccinations for children compared to male parents (aPR 0.72; 95%CI 0.62–0.84), while parents in the Western region of the US were more likely to report missed vaccinations compared to other regions (aPR 1.47; 95%CI 1.21–1.78) (Table 3).

Table 3.

Unadjusted and adjusted prevalence ratios for missed routine medical visits and missed vaccinations among US children ≤12 years of age (survey conducted March 2021).


Delayed or missed routine care
Missed vaccination
aPRa 95%CI p-value aPR 95%CI p-value
Child's age (ref: <2 years)
 2–6 years 1.82 1.47–2.26 <0.0001 0.94 0.76–1.16 0.56
 7–12 years 1.86 1.48–2.33 <0.0001 0.94 0.75–1.18 0.61
Child's sex (ref: Male)
 Female 1.05 0.94–1.18 0.40 0.95 0.83–1.10 0.49
Child's race/ethnicity (ref: White non-Hispanic)
 Non-Hispanic black 0.91 0.73–1.15 0.43 1.07 0.83–1.40 0.60
 Asian 1.04 0.78–1.38 0.79 1.41 1.10–1.81 0.01
 Hispanic 1.31 1.14–1.51 <0.001 1.01 0.85–1.21 0.91
 Other 0.90 0.71–1.16 0.42 0.72 0.51–1.02 0.06
Child has insurance (ref: No/Don't know)
 Yes 0.98 0.79–1.21 0.86 1.07 0.81–1.40 0.65
Child attending in person school/daycare ≥ 1 day per week (ref: No/DK)
 Yes 1.06 0.93–1.20 0.36 1.06 0.90–1.24 0.49
Parent age (ref: 45–64 years)
 18–29 years 1.14 0.91–1.43 0.27 1.32 0.98–1.78 0.07
 30–44 years 0.94 0.80–1.11 0.48 1.14 0.92–1.43 0.24
Parent's sex (ref: Male)b
 Female 0.88 0.77–1.00 0.05 0.72 0.62–0.84 <0.0001
Parental education level (ref: College or more)
 High school or less 0.88 0.73–1.05 0.16 0.95 0.76–1.18 0.62
 Some college 0.93 0.81–1.07 0.33 0.87 0.73–1.03 0.11
Number children in household < 12 years (ref: (Schuchat and Team, 2020)
 2 1.08 0.96–1.23 0.21 1.05 0.90–1.22 0.55
 3 or more 1.24 1.03–1.49 0.02 1.02 0.81–1.28 0.89
Household income USD (ref: ≥$100,000 k)
 <$25,000 0.81 0.65–1.01 0.07 0.76 0.58–1.01 0.06
 $25,000–$49,999 0.76 0.63–0.91 <0.01 0.80 0.64–1.01 0.06
 $50,000–$99,999 0.87 0.76–1.00 0.06 0.79 0.66–0.94 0.06
Region (ref: Northeast)
 South 0.96 0.83–1.11 0.59 1.17 0.97–1.42 0.10
 Midwest 0.93 0.79–1.10 0.42 1.22 0.99–1.50 0.06
 West 0.94 0.80–1.10 0.46 1.47 1.21–1.78 <0.0001

Abbreviations: CI = confidence interval; USD = US dollars. a Adjusted models included all variables shown in table. b Parents identifying as transgender were grouped with their identified gender (parents race/ethnicity excluded from adjusted models due to collinearity with child's race/ethnicity).

Most parents (71.2%; 95%CI 68.9–73.6) reported their child had attended an in-person medical care visit since the start of the COVID-19 pandemic, 29.8% (95%CI 27.6–32.1) reported a telemedicine visit, and 10.0% (95%CI 8.4–11.6) reported their child had received no medical care (Fig. 2 ). Attendance at in-person care visits was more common among children <2 years (83.3%; 95%CI 77.9–88.8) compared to 7–12-year-old children (63.3%; 95%CI 59.6–67.0) (p < 0.001) while older children (7–12 years) were more likely to have had telemedicine visits compared to younger children (33.6%, 95%CI 30.0–37.2 vs. 22.3%, 95%CI 17.4–27.3; p < 0.002). Urgent care or emergency room visits for children were reported for a higher proportion of Hispanic (22.5%, 95%CI 18.1–26.9) compared to Asian children (11.5%, 95%CI 3.7–19.3; p = 0.03). (See Fig. 1.)

Fig. 2.

Fig. 1

Medical care attended by US children ≤12 years during the first 12 months of the COVID-19 pandemic as reported by parents (as of March 2021).

4. Discussion

The COVID-19 pandemic has disrupted routine pediatric medical care, including vaccinations. In our survey of US parents conducted in March 2021, more than 40% reported that their youngest child had missed a routine medical care visit as a result of the COVID-19 pandemic but most children (79%) subsequently attended catch-up care. A third (33.1%) of US parents also reported that their child had missed a required vaccination and only 65% said they planned to take the child to receive the needed vaccine. Our findings on missed care and vaccination during the COVID-19 pandemic are consistent with the few studies to date assessing its impact on uptake of routine pediatric preventive care (Bode et al., 2021; Mehrotra et al., 2020). Most existing reports have focused on vaccination uptake and showed steep declines in the early months of the pandemic with indications of catch-up, primarily in younger children, by mid-2020 (Bramer et al., 2020; Langdon-Embry et al., 2020; Ackerson et al., 2021; Bode et al., 2021; Whaley et al., 2020). Our study measured any event of missed care or vaccination since the start of the pandemic, thus we cannot comment on changes in rates of missed care over the course of the pandemic. However, our finding that most children who missed a visit subsequently attended care is suggestive of the same dynamic.

While many parents reported catch-up after missed care, almost a quarter said their child had not received care following a missed visit, and this was more likely among children older than 2 years and in Hispanic children. Pediatric preventive care or “well visits”, particularly for infants and young children, are important not only for assessing physical health and providing vaccinations (Bode et al., 2021), but also for conducting screening to mark developmental milestones and identify emotional and social issues (Hagan et al., 2017). While our data are reassuring in suggesting that most infants and younger children received recommended care, older children appear at higher risk for missed care. Studies conducted prior to the pandemic have also shown that older children and Hispanic children are less likely to attend recommended annual wellness visits (Uddin et al., 2016; Berdahl et al., 2020). Our findings may be an indication that the COVID-19 pandemic has exacerbated these trends which is concerning and should be examined further.

We also found high prevalence of missed vaccination which may be an underestimate given that not all parents may have been notified about a child's missed vaccination. High levels of vaccination are needed to prevent outbreaks of diseases including measles and pertussis. Our data, along with reports from vaccine registries showing decreased vaccination uptake and coverage (Bramer et al., 2020; Langdon-Embry et al., 2020; Ackerson et al., 2021) are very concerning, particularly as the US returns to pre-pandemic activities, including in-person education. The easing of social distancing and reduced mask wearing could fuel outbreaks of vaccine-preventable illnesses among unvaccinated children (Sull et al., 2014; Guha-Sapir et al., 2020; Perrone and Meissner, 2020). In addition, while influenza activity (diagnoses, hospitalization and deaths) was significantly lower in 2020–21 compared to previous years, likely due to COVID-19 mitigation efforts (Uyeki et al., 2021), the drop in flu vaccinations we observed among children is troubling. Our data are consistent with a CDC report showing influenza vaccine doses administered to children 6–23 months were 13.9% lower and to 2–4 year olds were 11.9% lower from September through December 2020 compared to the same months in 2018 and 2019 (Roman et al., 2021). Prior to the COVID-19 pandemic, influenza vaccination rates in US children had stalled (Tian et al., 2019; Santibanez et al., 2020) and the pandemic may have eroded the progress made over the past decades. We also found that among parents who said their child had missed a vaccine but did not plan to take the child to get it, almost 20% said it was because they did want the child to get the vaccine. These findings are not a direct measure of vaccine hesitancy and we do not have data on vaccine hesitancy prior to the COVID-19 pandemic, however it is important to note that a small number of studies have documented increases in parental vaccine hesitancy during the COVID-19 pandemic which is very concerning (He et al., 2022; Sokol and Grummon, 2020).

Based on our data and those from similar studies, it is clear that targeted strategies are needed to ensure routine care and vaccination catch-up for US children. These efforts are urgently needed to ensure the safety and well-being of children. An important strategy for addressing gaps in care will be outreach by pediatricians to the parents of patients who are still out of care and who missed vaccinations during the pandemic, with a focus on older children and Hispanic children. In addition, efforts are needed for coming flu seasons to ensure wider coverage of influenza vaccination in pediatric populations (Sokol and Grummon, 2020).

While our study provides important information about the prevalence of missed routine pediatric preventive care during the COVID-19 pandemic, it has some limitations. We collected data at one point in time to measure cumulative experience over the first year of the COVID-19 pandemic and we cannot comment on trends over time. Our survey focused on children 12 years of age and under in an effort to sample younger children, and thus, we do not have data on adolescents. The survey data were self-reported by parents and caregivers and are therefore subject to recall, response and social desirability biases. In addition, while our survey was weighted to reflect the US population of parents based on 2019 census estimates, it was conducted online through opt-in panels which excludes parents without internet access. However, data from the National Center for Education Statistics show that in 2019, 95% of US children and adolescents ≤18 years had home internet access (National Center for Education Statistics (NCES), 2021). Finally, our information on missed vaccinations is limited as parents and caregivers may not be aware of when children are due for vaccines and pediatric practices may not have contacted parents to alert them to missed vaccinations. We did not verify reports with medical records, however previous validation of self-reported influenza vaccination with medical records has shown high agreement (King et al., 2018).

5. Conclusions

Our study contributes to a greater understanding of how the COVID-19 pandemic has affected continuity of routine pediatric care for US children and provides critical information about the urgent need to address gaps in pediatric preventive care which could negatively impact the health and wellbeing of children, their families and communities.

Declaration of Competing Interest

The authors report no conflicts; no authors have financial interests.

Acknowledgments

Acknowledgments

This study was funded by the CUNY Institute for Implementation Science in Population Health, New York, NY, USA. Author contributions: Chloe Teasdale: conceptualization, study methodology including survey instrument, data analysis and manuscript drafting; Yanhan Shen and Rebecca Zimba: data analysis, visualization and manuscript review; Luisa Borrell and Denis Nash: study methodology, survey instrument design, data review, and manuscript writing and editing; Spencer Kimball: sampling methodology, data procurement and cleaning, and manuscript review; Michael Rinke, Madhura Rane, Sarah Kulkarni and Sasha Fleary: survey instrument design and manuscript writing and editing review. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.

Funding/Support

This study was funded by the CUNY Institute for Implementation Science in Population Health, New York, NY, USA.

Role of funding/sponsor

The study was internally funded by the researchers' institution.

CRediT author statement

Chloe Teasdale: conceptualization, investgation, methodology, formal analysis, supervision, writing-original draft; Yanhan Shen and Rebecca Zimba: formal analysis, visualization and writing-review; Luisa Borrell and Denis Nash: methodology, resources, and writing-review; Spencer Kimball: methodology, data curation and writing-review; Michael Rinke, Madhura Rane, Sarah Kulkarni and Sasha Fleary: methodology and writing-review.

Footnotes

Appendix A

Supplementary data to this article can be found online at https://doi.org/10.1016/j.ypmed.2022.107025.

Appendix A. Supplementary data

Supplementary material

mmc1.pdf (458.2KB, pdf)

References

  1. Ackerson B.K., Sy L.S., Glenn S., et al. Pediatric vaccination during the COVID-19 pandemic. Pediatrics. 2021 Jul;148(1) doi: 10.1542/peds.2020-047092. [DOI] [PubMed] [Google Scholar]
  2. American Association for Public Opinion Research (AAPOR) Standard Defintions: Final Dispositions of Case Codes and Outcome Rates for Surveys. 2022. https://www.aapor.org/AAPOR_Main/media/publications/Standard-Definitions20169theditionfinal.pdf Accessed January 13, 2021.
  3. Berdahl T., Biener A., McCormick M.C., Guevara J.P., Simpson L. Annual report on children’s healthcare: healthcare access and utilization by obesity status in the United States. Acad. Pediatr. 2020;20(2):175–187. doi: 10.1016/j.acap.2019.11.020. [DOI] [PubMed] [Google Scholar]
  4. Bleser W.K., Miranda P.Y., Salmon D.A. Child influenza vaccination and adult work loss: reduced sick leave use only in adults with paid sick leave. Am. J. Prev. Med. 2019;56(2):251–261. doi: 10.1016/j.amepre.2018.09.013. [DOI] [PubMed] [Google Scholar]
  5. Bode S.M., Gowda C., Mangini M., Kemper A.R. COVID-19 and primary measles vaccination rates in a large primary care network. Pediatrics. 2021;147(1) doi: 10.1542/peds.2020-035576. [DOI] [PubMed] [Google Scholar]
  6. Bramer C.A., Kimmins L.M., Swanson R., et al. Decline in child vaccination coverage during the COVID-19 pandemic - Michigan care improvement registry, may 2016-may 2020. Am. J. Transplant. 2020;20(7):1930–1931. doi: 10.1111/ajt.16112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. CDC Recommended Child and Adolescent Immunization Schedule for Ages 18 Years or Younger, United States. 2020. https://www.cdc.gov/vaccines/schedules/hcp/imz/child-adolescent.html Accessed July 20, 2020.
  8. Courtney J.G., Chuke S.O., Dyke K., et al. Decreases in young children who received blood Lead level testing during COVID-19 - 34 jurisdictions, January-may 2020. MMWR Morb. Mortal. Wkly Rep. 2021;70(5):155–161. doi: 10.15585/mmwr.mm7005a2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Guha-Sapir D., Moitinho de Almeida M., Keita M., Greenough G., Bendavid E. COVID-19 policies: remember measles. Science. 2020;369(6501):261. doi: 10.1126/science.abc8637. [DOI] [PubMed] [Google Scholar]
  10. Hagan J.F., Shaw J.S., Duncan P.M. Fourth edition. ed. Bright Futures/American Academy of Pediatrics; Elk Grove Village, IL: 2017. Bright Futures : Guidelines for Health Supervision of Infants, Children, and Adolescents. [Google Scholar]
  11. He K., Mack W.J., Neely M., Lewis L., Anand V. Parental perspectives on immunizations: impact of the COVID-19 pandemic on childhood vaccine hesitancy. J. Community Health. 2022;47:39–52. doi: 10.1007/s10900-021-01017-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. King J.P., McLean H.Q., Belongia E.A. Validation of self-reported influenza vaccination in the current and prior season. Influenza Other Respir. Viruses. 2018;12(6):808–813. doi: 10.1111/irv.12593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Langdon-Embry M., Papadouka V., Cheng I., Almashhadani M., Ternier A., Zucker J.R. Notes from the field: rebound in routine childhood vaccine administration following decline during the COVID-19 pandemic - new York City, march 1-June 27, 2020. MMWR Morb. Mortal. Wkly Rep. 2020;69(30):999–1001. doi: 10.15585/mmwr.mm6930a3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Mehrotra A., Chernew M.E., Linetsky D., Hatch H., Cutler D.A., Schneider E.C. The impact of the COVID-19 pandemic on outpatient care: visits return to prepandemic levels, but not for all providers and patients. Commonwealth Fund. Oct 2020 doi: 10.26099/41xy-9m57. [DOI] [Google Scholar]
  15. Miller C.A., Guidry J.P.D., Dahman B., Thomson M.D. A tale of two diverse Qualtrics samples: information for online survey researchers. Cancer Epidemiol. Biomark. Prev. 2020;29(4):731–735. doi: 10.1158/1055-9965.EPI-19-0846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. National Center for Education Statistics (NCES) Children's Internet Access at Home. 2021. https://nces.ed.gov/programs/coe/indicator/cch Accessed December 23, 2021.
  17. Perrone O., Meissner H.C. The importance of MMR immunization in the United States. Pediatrics. 2020;146(2) doi: 10.1542/peds.2020-0251. [DOI] [PubMed] [Google Scholar]
  18. Roman P.C., Kirtland K., Zell E.R., et al. Influenza vaccinations during the COVID-19 pandemic - 11 U.S. jurisdictions, September-December 2020. MMWR Morb. Mortal. Wkly Rep. 2021;70(45):1575–1578. doi: 10.15585/mmwr.mm7045a3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Santibanez T.A., Srivastav A., Zhai Y., Singleton J.A. Trends in childhood influenza vaccination coverage, United States, 2012-2019. Public Health Rep. 2020;135(5):640–649. doi: 10.1177/0033354920944867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Santoli J.M., Lindley M.C., DeSilva M.B., et al. Effects of the COVID-19 pandemic on routine pediatric vaccine ordering and administration - United States, 2020. MMWR Morb. Mortal. Wkly Rep. 2020;69(19):591–593. doi: 10.15585/mmwr.mm6919e2. [DOI] [PubMed] [Google Scholar]
  21. Schuchat A., Team C.C.-R. Public health response to the initiation and spread of pandemic COVID-19 in the United States, February 24-April 21, 2020. MMWR Morb. Mortal. Wkly Rep. 2020;69(18):551–556. doi: 10.15585/mmwr.mm6918e2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Sokol R.L., Grummon A.H. COVID-19 and parent intention to vaccinate their children against influenza. Pediatrics. 2020;146(6) doi: 10.1542/peds.2020-022871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Strengthening the reporting of observational studies in epidemiology (STROBE) Checklist for Cross-Sectional Studies. 2007. https://www.strobe-statement.org/index.php?id=available-checklists Accessed January 13, 2021.
  24. Sull M., Eavey J., Papadouka V., Mandell R., Hansen M.A., Zucker J.R. Adolescent vaccine co-administration and coverage in new York City: 2007-2013. Pediatrics. 2014;134(6):e1576–e1583. doi: 10.1542/peds.2014-1452. [DOI] [PubMed] [Google Scholar]
  25. Tian C., Wang H., Wang W., Luo X. Influenza vaccination coverage among US children from 2004/2005 to 2015/2016. J. Public Health. 2019;41(1):e62–e69. doi: 10.1093/pubmed/fdy081. [DOI] [PubMed] [Google Scholar]
  26. Uddin S.G., O’Connor K.S., Ashman J.J. Physician office visits by children for well and problem-focused care: United States, 2012. NCHS Data Brief. 2016;248:1–8. [PubMed] [Google Scholar]
  27. US Census Bureau (USC) National Survey of Chlidren's Health. 2020. https://www.childhealthdata.org/learn-about-the-nsch/NSCH Accessed February 23, 2021.
  28. US Centers for Disease Control and Prevention (CDC) US Centers for Disease Control and Prevention; Atlanta, GA: 2020. Framework for Non-Covid Care. [Google Scholar]
  29. USC Census QuickFacts. 2019. https://www.census.gov/quickfacts/fact/table/US/PST045219 Accessed January 5, 2021.
  30. Uyeki T.M., Wentworth D.E., Jernigan D.B. Influenza activity in the US during the 2020-2021 season. JAMA. 2021;325(22):2247–2248. doi: 10.1001/jama.2021.6125. [DOI] [PubMed] [Google Scholar]
  31. Walsh B., Doherty E., O’Neill C. Since the start of the vaccines for children program, uptake has increased, and most disparities have decreased. Health Aff. 2016;35(2):356–364. doi: 10.1377/hlthaff.2015.1019. [DOI] [PubMed] [Google Scholar]
  32. Weinberger D.M., Chen J., Cohen T., et al. Estimation of excess deaths associated with the COVID-19 pandemic in the United States, march to may 2020. JAMA Intern. Med. 2020;180(10):1336–1344. doi: 10.1001/jamainternmed.2020.3391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Whaley C.M., Pera M.F., Cantor J., et al. Changes in health services use among commercially insured US populations during the COVID-19 pandemic. JAMA Netw. Open. 2020;3(11) doi: 10.1001/jamanetworkopen.2020.24984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Woolf S.H., Chapman D.A., Sabo R.T., Weinberger D.M., Hill L., Taylor D.D.H. Excess deaths from COVID-19 and other causes, march-July 2020. JAMA. 2020;324(15):1562–1564. doi: 10.1001/jama.2020.19545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Zucker J.R., Rosen J.B., Iwamoto M., et al. Consequences of Undervaccination - measles outbreak, new York City, 2018-2019. N. Engl. J. Med. 2020;382(11):1009–1017. doi: 10.1056/NEJMoa1912514. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary material

mmc1.pdf (458.2KB, pdf)

Articles from Preventive Medicine are provided here courtesy of Elsevier

RESOURCES